In summary our findings illustrate that E2F1 and E2F8 are expressed in pancreatic progenitor and PDAC cells, where they contribute to tumor cell expansion by regulation of cell proliferation, viability and cell migration making these genes attractive therapeutic targets and potential prognostic markers for pancreatic cancer. This evidence concerns the gene E2F1 and familial pancreatic carcinoma.